William A. Goolsbee

William A. Goolsbee joined the board in October of 2019. Mr. Goolsbee is an experienced life sciences professional with decades of leadership in both the Medical Device and Pharmaceutical sectors. Mr. Goolsbee was founder, Chairman and Chief Executive Officer of Horizon Medical Inc. from 1987 until its acquisition by a unit of UBS Private Equity in 2002. He was a founding Director of ImmunoTherapy Corporation in 1993, and became Chairman in 1995, a position he held until overseeing the successful acquisition of ImmunoTherapy by AVI Biopharma, Inc. (now Sarepta Therapeutics) in 1998. Mr. Goolsbee served as Chairman of privately held BMG Pharma LLC, a pharmaceutical company, from 2006 through 2011 and of Metrodora Therapeutics until 2015. Mr Goolsbee is currently a member of the board of directors of Antisense Therapeutics and was until the end of 2016 a Director of Sarepta Therapeutics Inc.; both companies focus on rare disease drug development. Mr. Goolsbee received his B.A. in English from the University of California in 1977.

With his background in rare disease drug development and his years of experience serving on the boards of other companies, Mr. Goolsbee brings to the board demonstrated leadership ability and a solid understanding of corporate governance, which also makes him a valuable contributor to the board committees.